SAGAN PAUL bought MRNA
April 30, 2025 · Form 4 insider transaction
SAGAN PAUL bought 25,512 shares of Moderna, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
25,512
Price
$0.00
Total value
N/A
InsiderSAGAN PAUL
Role—
CompanyModerna, Inc. (MRNA)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 30, 2025
Filing dateMay 1, 2025
Shares owned after25,512
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option will become fully vested and exercisable on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.